MedPath

ONO-7913-03: ONO-7913 Phase 1 Study

Phase 1
Conditions
ntreated metastatic pancreatic cancer
Registration Number
JPRN-jRCT2031210172
Lead Sponsor
Hirashima Yoshinori
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1. Untreated metastatic pancreatic cancer
2. Life expectancy of at least 3 months
3. Patients with ECOG performance status 0 or 1

Exclusion Criteria

1. Patients with severe complication
2. Patients with multiple primary cancers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath